SR
Sarojni Rambal
About Sarojni Rambal
Data last updated:
Sarojni Rambal is a Director at Perdaman Pharmaceuticals Private Limited (since 2017) and Director at Shirdi Bio Fuels Private Limited (since 2017). The companies operate in Pharma, Agriculture and Media and Publishing. The 2 current companies with reported revenue have a combined latest revenue of ₹29.39 Cr; the largest is Perdaman Pharmaceuticals Private Limited at ₹28.76 Cr (FY 2025). Earlier, Sarojni Rambal was a Director at Sunrise International Labs Limited (2017–2025) and Director at Perdaman Corporate Services Private Limited (2008–2010).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Jan 2017 | 2008 | ₹28.76 Cr (FY 2025) | Active | |
| Director | 24 Jan 2017 | 2007 | ₹62.6 Lakh (FY 2020) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Jan 2017 | 1993 | ₹21.39 Cr (FY 2024) | Active | |
| Director | 07 Jul 2008 | 2008 | ₹68.8 Lakh (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sarojni Rambal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dhruv Garg | Perdaman Pharmaceuticals Private Limited | Company Secretary | |
| Manoj Kumar Rambal | 02527855 | Perdaman Pharmaceuticals Private Limited | Director |
| Samir Madhukar Garud | 06681637 | Perdaman Pharmaceuticals Private Limited | Director |
| Shubham Kumar Namdev | Perdaman Pharmaceuticals Private Limited | Company Secretary | |
| Usha Rambal | 02527942 | Perdaman Pharmaceuticals Private Limited | Director |
| Vikas Rambal | 01759802 | Perdaman Pharmaceuticals Private Limited , Shirdi Bio Fuels Private Limited | Director |
| Avinash | 11465215 | Shirdi Bio Fuels Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sarojni Rambal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sarojni Rambal
Sarojni Rambal currently holds 2 directorships: Perdaman Pharmaceuticals Private Limited (Director, since 24 Jan 2017, revenue ₹28.76 Cr (FY 2025)); Shirdi Bio Fuels Private Limited (Director, since 24 Jan 2017, revenue ₹62.6 Lakh (FY 2020)).
Sarojni Rambal was first appointed on 07 Jul 2008 as Director at Perdaman Corporate Services Private Limited. The most recent appointment on record is 24 Jan 2017 at Sunrise International Labs Limited.
The 2 current companies of Sarojni Rambal that report revenue have a combined latest revenue of ₹29.39 Cr: Perdaman Pharmaceuticals Private Limited ₹28.76 Cr (FY 2025); Shirdi Bio Fuels Private Limited ₹62.6 Lakh (FY 2020).
Sarojni Rambal held 2 earlier board appointments: Sunrise International Labs Limited (Director, 24 Jan 2017 to 02 Apr 2025); Perdaman Corporate Services Private Limited (Director, 07 Jul 2008 to 15 Oct 2010).
The current boards of Sarojni Rambal's companies include Dhruv Garg (Perdaman Pharmaceuticals Private Limited), Manoj Kumar Rambal (Perdaman Pharmaceuticals Private Limited), Samir Madhukar Garud (Perdaman Pharmaceuticals Private Limited), Shubham Kumar Namdev (Perdaman Pharmaceuticals Private Limited), Usha Rambal (Perdaman Pharmaceuticals Private Limited), Vikas Rambal (Perdaman Pharmaceuticals Private Limited), among others.